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Abstract:  
 
Antibiotic use is the driving force for increasing antibiotic resistance. A large 
proportion of antibiotics in hospitals are used inadequately. The objective of this 
study was to evaluate antibiotic use at the Hospital for Infectious Diseases through 
point-prevalence surveys conducted in 2006, 2008 and 2009.  
 
Point prevalence surveys were part of the European Surveillance on Antimicrobial 
Consumption (ESAC) Hospital Care Subproject and patients` data were collected 
following ESAC protocol. Additionally, the adequacy of antimicrobial therapy and 
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administration of the first line antibiotic according to the local guidelines were 
assessed by an infectious disease doctor and a clinical microbiologist.   
 
In the study period among the 599 patients admitted to hospital, 352 (58.8%) 
received antibiotics. Out of 448 antimicrobial treatments, 313 (69.9%) were 
administered parenterally and 135 (30.1%) orally. Altogether in years 2006, 2008 
and 2009 the most commonly prescribed antibiotics were ceftriaxone (19.9%), co-
amoxiclav (15.4%), ciprofloxacin (12.3%), narrow spectrum penicillins (6.5%) 
and penicillinase resistant penicillins (5.6%). Most (82.6%) of the treated 
infections were community acquired infections. The predominating diagnoses 
were urinary tract infections and infections with no primary site defined, followed 
by skin, soft tissue and bone and joint infections. The overall adequacy of 
antimicrobial therapy was > 90% and the first line antibiotic according to the local 
guidelines was administered with high frequency for central nervous system and 
cardiovascular infections (100%), and low for ear, nose and throat infections, 
urinary tract infections, lower respiratory tract and bone and joint infections 
(23.0%, 51.6%, 52.5%, 65.0%, respectively) which indicates a significant overuse 
of antibiotics for diagnoses listed.  
  
The results of an individual PPS provided reliable and representative data for the 
hospital.  
Point-prevalence surveys proved to be a valuable method for detecting targets for 
antibiotic prescribing improvement and they clearly showed that our local hospital 
guidelines offered too many choices of antibiotic treatment for each clinical 
indication and needed revision. 
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Introduction 
 
Irrational and extensive antibiotic use is one of the factors that has led to an 
increase in antibiotic resistance which became a major public health challenge at 
local, national and international levels 
1,2,3,4
.
 
 It was reported that 20 – 50 % of 
antimicrobial use in human population is inappropriate 
5,6
,  and estimated that 
more than 50% of antibiotic prescriptions in the United States may be 
inappropriate considering the drug choice, dose adequacy, duration of therapy or 
route of administration 
2,7,8
. Although hospital antibiotic consumption accounts for 
5 – 15 % of the overall antibiotic exposure in the European countries, hospitals are 
held responsible for the increase of resistance due to high use of broad spectrum 
antibiotics 
9,10,11,12,13
.  
 
Antimicrobial resistance control measures are commonly perceived to lead to an 
improvement in quality of prescribing, cost-effectiveness and reduction in 
resistance. Several different approaches have been proposed to reduce antibiotic 
resistance. Besides continuous education of physicians, control of antibiotic 
prescribing and better infection control practices are thought to be the most 
important measures. One of the frequently used surveillance methods for internal 
quality control in antibiotic prescribing is a point prevalence survey (PPS) of 
antibiotic use in hospitals. It is used to evaluate the prevalence of antibiotic use 
and the appropriateness of antibiotic therapy 
14,15,16,17,18,19
. 
 
The aim of this study was to evaluate the prevalence and patterns of antimicrobial 
prescribing for main indications at the Zagreb University Hospital for Infectious 
Diseases. We also tried to assess the adequacy of antimicrobial treatment and 
compliance with local guidelines for the management of infectious diseases. 
 
 
Materials and methods 
 
The Hospital 
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The University Hospital for Infectious Diseases is a 232 – bed hospital with seven 
medical and three paediatric wards. It is the national referral hospital for infectious 
diseases, in particular for patients with AIDS, hepatitis, urinary tract infections 
and tropical and travel diseases. It is also the reference center for antibiotic 
resistance surveillance. The hospital has one 12- bed adult intensive care unit 
(AICU) and one seven bed paediatric intensive care unit (PICU). The AICU also 
contains six post intensive care beds and antibiotic consumption data are reported 
for the combined ICU and post ICU ward. PICU is also a part of the 21- bed 
paediatric ward and antibiotic consumption data for PICU cannot be separated 
from the rest of this paediatric ward. The number of admissions for the whole 
hospital was 7599 in 2006, 7351 in 2008 and 7198 in 2009, and bed occupancy 
was 69651 in 2006, 70106 in 2008 and 68855 in 2009.  
   
Data collection 
The PPS on antibiotic consumption was done in 2006, 2008 and 2009, as a part of 
the European Surveillance on Antimicrobial Consumption (ESAC)-2 and ESAC-3 
Hospital Care Subproject. In 2006 the software used for data entry was based on 
Swedish STRAMA software whilst in 2008 and 2009 the ESAC web-based 
survey program (WebPPS) was developed by ESAC. The protocol used in ESAC-
2 survey was similar to that used in ESAC-3 PPS 2008 and ESAC-3 PPS 2009 
20
. 
The survey in our hospital was carried out by a microbiologist and an infection 
control nurse who collected the required data by examining patients' notes 
available at the ward. For the purpose of this study the adequacy of applied 
treatment as well as the proportion of treatments matching the first line antibiotic 
recommended by the local guidelines were assessed. This was evaluated by a team 
consisting of an infectious disease doctor and a clinical microbiologist. Therapy 
was recorded as adequate if it covered an expected or proven pathogen at the 
specific site of infection. The use of the first choice antimicrobial according to the 
local guidelines was used as a marker of compliance with the local guidelines. 
Compliance with the first line antibiotic according to the local guidelines was 
assesed administratively irrespective of the presence or absence of conditions that 
might require second line antibiotics. 
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All inpatients receiving antimicrobials for treatment or prophylaxis present at 8 
am in the hospital on the day of the audit were included in the survey. It took two 
days for each PPS to audit all wards. Antibiotics belonging to the J01, J02, P01AB 
and J04AB02 according to The Anatomical Therapeutic Chemical (ATC) 
classification by the WHO Collaborating Centre for Drug Statistics were recorded 
and included in the survey 
21
. Rifampicin was recorded for any indication but 
tuberculosis. 
 
For each patient receiving antibiotic treatment, demographic data, antibiotic 
treatment, dosage and route of administration, anatomical site of infection or 
target for prophylaxis according to the list of provided diagnosis groups, 
indication for therapy (community or hospital acquired infection, medical or 
surgical prophylaxis) and indication for given therapy stated in medical records 
was recorded on the patient form. The existence of relevant culture before therapy 
was recorded in 2006 and 2008.  
 
Guidelines for antibiotic use  
In the year 2000 a pocket formulary for prophylaxis and treatment of infectious 
diseases was issued by the Croatian Society for Chemotherapy 
22
.  The manual 
was distributed to every physician in the hospital and was used as the reference 
guideline in our survey. The formulary includes recommendations for the first and 
second line antibiotics for defined clinical indications.  
 
 
Statistics 
 
Descriptive statistical methods were used in order to assess frequency 
distributions, and cross tabulations. For testing the statistical significance of the 
difference of categorical variables' distributions between two groups, non-
parametric chi-square analytic tests were performed. In case of three or more 
groups, the Kruskal-Wallis non-parametric test was performed. Furthermore, 
where needed (the number of cases less than 5 in a number of strata) the Fisher`s 
exact test was performed. 
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Results 
 
Patients 
 
Altogether in three PPSs, performed in the years 2006, 2008 and 2009, a total of 
599 patients were evaluated (471 adults and 128 children). Out of them, 352 
(58.8%) received antimicrobials with 271 (76.9%) receiving one, 68 (19.3%) 
receiving two, 11 (3.1%) receiving three, and two (0.6%) patients receiving four 
antimicrobials. Their mean age was 51,23 (CI= 48.81-53.66), and median age 57 
years. Out of 352 patients receiving antimicrobials, 186 (52.8%) were males. 
There were no statistically significant yearly differences according to sex (chi-
square=2.030, df=2, p=0.362). Out of the total of 352 patients receiving 
antibiotics, 144 (40.9%) patients were ≥65 years old, 144 (40.9%) patients were 
aged between 18-64 years and 64 (18.2%) patients were <18 years old.  
 
Antibiotic use 
 
Out of 98 patients treated in ICU, 37 (37.8%) received antibiotics. In medical 
wards 304 (64.5%) out of 471 adult patients were given antibiotics. Out of 128 
patients admitted to paediatric wards, 48 (37.5%) received antimicrobials. In 
PICU 16 ( 37.2%) out of 43 children underwent antibiotic therapy.  
 
Out of 448 antimicrobial treatments, 313 (69.9%) were administered parenterally 
and 135 (30.1%) orally. The proportion of patients receiving antibiotics per type 
of department and per year is shown in Table 1 together with characteristics 
related to antibiotic treatment, such as route of administration, percentage of 
monotherapy, the existence of relevant culture before therapy and explained 
reasons for the given therapy recorded in patients' notes.  
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Table 1. Patients` data. 
 2006 2008 2009 Total Difference 
among 
study 
periods 
(P<0.05) 
No. of patients 
admitted 
184 227 188 599  
No. of patients 
on antibiotic (% 
of patients 
admitted) 
108 (58.7) 132 (58.1) 112 (59.6) 352 (58.8) 0.956 
No. of paediatric 
patients 
admitted (% of 
patients 
admitted) 
37 (20.1) 61 (26.9) 30 (15.9) 128 (21.4) 0.023 
No. of paediatric 
patients on 
antibiotic (% of 
paediatric 
patients 
admitted) 
14 (37.8) 20 (32.8) 14 (46.7) 48 (37.5) 0.810 
No. of adult 147 (79.9) 166 (73.1) 158 (84.0) 471 (78.6) 0.023 
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patients 
admitted (% of 
patients 
admitted) 
No. of adult 
patients on 
antibiotic (% of 
adult patients 
admitted) 
94 (63.9) 112 (67.5) 98 (62.0) 304 (64.5) 0.810 
No. of patients 
admitted at 
PICU* (% of 
paediatric 
patients) 
10 (27.0) 23 (37.7) 10 (33.3) 43 (33.6) 0.554 
No. of PICU 
patients with 
antibiotic (% of 
PICU patients) 
6 (60.0) 6 (26.1) 4 (40.0) 16 (37.2) 0.176 
No. of patients 
admitted to 
AICU** (% of 
adult patients) 
13 (8.8) 27 (16.3) 15 (9.5) 55 (11.7) 0.072 
No. of AICU 
patients with 
6 (46.2) 9 (33.3) 6 (40.0) 21 (38.2) 0.726 
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antibiotic (% of 
AICU patients) 
Percentage of 
females*** (%) 
61 (56.5) 
 
63 (47.7) 
 
42 (37.5) 
 
166 (47.2) 
 
0.362 
Parenteral route 
(%) 
77 (59.7) 
 
131 (74.0) 
 
105 (73.9) 
 
313 (69.9) 
 
0.002 
Monotherapy 
(%) 
88 (81.5) 97 (73.5) 86 (76.8) 271 (76.9) 0.341 
Relevant culture 
before therapy 
(%) 
114 (88.3) 127 (71.8) / 241 (78.8) <0.001 
Reason for 
therapy stated in 
patients` notes 
(%) 
96 (74.4) 158 (89.2) 131 (92.3) 385 (85.9) <0.001 
 
*PICU = paediatric intensive care unit 
**AICU = adult intensive care unit    
*** of patients receiving antimicrobials 
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Indication for therapy 
 
Most (82.6%) of the treated infections were community acquired infections. 
Hospital acquired infections accounted for 12.9% of all infections, and medical 
prophylaxis accounted for only 4.5%. There were no statistically significant 
differences in indications for antimicrobial therapy according to year of PPS (chi-
square=6.78, df=4, P=0.148) (Table 2).  
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Table 2. Indications for antimicrobial therapy. 
Indications for therapy 2006 (%) 2008 (%) 2009 (%) Total (%) 
Community acquired 
infections 
107 (82.9) 142 (80.2) 121 (85.2) 370 (82.6) 
HCAI*  1 0             
13 (10.1) 
4 (2.3)             
30 (17.0) 
3 (2.1)             
15 (10.6) 
7 (1.5)                        
58 (12.9) 
HCAI*  2 6 6 (3.3) 1 (0.7) 13 (2.9) 
HCAI*  3 2 0 2 (1.5) 4 (0.8) 
HCAI*  4 0 4 (2.3) 4 (2.8) 8 (1.8) 
HCAI*  5 5 16 (9.0) 5 (3.5) 26 (5.8) 
Medical prophylaxis 9 (7.0) 5 (2.8) 6 (4.2) 20 (4.5) 
Total 129 177 142 448 
 
*HCAI = health care associated infections 
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Diagnoses leading to antibiotic use 
 
The proportion of diagnoses leading to antibiotic use is shown in Figure 1.  
In 2006, 2008 and 2009 the most frequent diagnosis groups were SSTBJ, UTI and 
NDS, respectively. The differences in diagnosis group distribution according to 
year of PPS were statistically significant (chi-square=17.82, df=8, P=0.022). 
 
 
Figure 1. The proportion of diagnoses leading to antibiotic use 
 
The proportion of antibiotics used  
 
As shown in Figure 2, the top five ranking antibiotics for the three PPSs were 
ceftriaxone (19.9%), co-amoxiclav (15.4%), ciprofloxacin (12.3%), narrow 
spectrum penicillins - benzylpenicillin, benzathine benzylpenicillin, procaine 
benzylpenicillin (6.5%) and penicillinase resistant penicillins - cloxacillin, 
flucloxacillin (5.6%). There were no statistically significant differences between 
the years when looking at the whole panel of antibiotics used (Kruskal Wallis chi 
square=0.784, df=2, P=0.676), or the first ten antibiotics (Pearson chi-
square=1.131, df=18, P=0.568), or even the top five antibiotics (Pearson chi-
square=13.160, df=8, P=0.106). 
 
  
Figure 2. The ranking of antibiotics used 
 
Antibiotics per clinical diagnosis 
 
There was a statistically significant difference according to year in antibiotic 
administration for the top three antibiotics used for UTI (Chi-square=16.55, df=6, 
P=0.011). The most frequently used antibiotic in 2006 and 2008 was co-
amoxiclav and in 2009 ceftriaxone. 
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There was no statistically significant difference by year in antibiotic 
administration for the top three antibiotics used for NDS (Fisher`s exact test 
P=0.254). The most frequently used antibiotics in all three years were ceftriaxone 
and co-amoxiclav.  
There was no statistically significant difference by year in antibiotic 
administration for the top three antibiotics used for SSTBJ (Fisher`s exact test 
P=0.767). The most frequently used antibiotics in all three years were narrow 
spectrum penicillins. 
There was no statistically significant difference by year in antibiotic 
administration for the top three antibiotics used for GI (Fisher`s exact test 
P=0.696). The most frequently used antibiotic in all three years were ciprofloxacin 
and ceftriaxone.  
There was no statistically significant difference by year in antibiotic 
administration for the top three antibiotics used for respiratory tract infections 
(Fisher`s exact test P=0.462). The most frequently used antibiotics in all three 
years were co-amoxiclav, azithromycin and ceftriaxone. In respiratory tract 
infections, as well as in GIT infections we excluded medical prophylaxis (co-
trimoxazol and fluconazole, respectively).  
 
Adequacy of antimicrobial therapy and compliance with the local guidelines 
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Table 3. Adequacy of antimicrobial therapy and administration of the first line 
antibiotic according to the local guidelines 
Diagnosis group* (No.) First line antibiotic (%) Adequate (%) 
CNS (35) 100 100 
ENT (22) 23 40.8 
RESP (55) 52.5 98.5 
CVS (10) 100 100 
GI (59) 71 100 
SST (59) 83 91 
BJ (24) 65 100 
UTI (95) 51.6 100 
GUOB (1) 100 100 
NDS (88) 34 97.7 
* abbreviations are the same as in Figure 1 
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Discussion 
 
Prevalence studies on antibiotic prescribing in hospitals report different 
proportions of patients receiving antibiotics with rates varying between 17 - 51% 
15,17,18,19,23,24,25,26
.  This study analyzed antimicrobial drug use in an infectious 
disease hospital and a high proportion of patients on antibiotics (approx. 60% in 
all three PPSs together) was expected. The three PPSs done in the same hospital 
revealed a very similar structure of patients admitted, a similar proportion of 
patients on antibiotics (Table 1) and a similar distribution of indications for 
therapy (Table 2) suggesting that the results of an individual PPS provide reliable 
and representative data for the hospital.  
 
Like in other reported studies no statistically significant differences by sex were 
noted 
15,16,17,19,28
.  A higher proportion of patients on antibiotics was recorded 
among adult (65%) than among paediatric (37.5%) patients which suggests that 
childhood viral infections are more common reason for admission to hospital than 
bacterial infections. Surprisingly the proportion of patients receiving antibiotics in 
adult ICU (38%) was below the rate for adults in the whole hospital (65%). This 
suggests that although bacterial infections are a more common reason for 
admission to our hospital in adult population, viral infections more often require 
admission to AICU. 
 
The predominance of the parenteral route (70%), as well as the high proportion of 
monotherapy (77%) is consistent with the findings of other authors and similar 
surveys 
27,28
. Over the years there was an improvement in keeping records of 
reasons for antibiotic therapy stated in the patients`notes. This might be the 
consequence of a more detailed administrative tasks imposed by the national 
health insurance system since 2006. However, no decrease in the use of parenteral 
antibiotics or increase in relevant culture before therapy (Table 1) were recorded, 
both of which are continuous recommendations of the hospital professional board.  
 
In this study, the community acquired infections present a higher proportion 
(83%) than the average recorded in the ESAC PPSs (66% in 2008, 62% in 2006) 
16 
 
27,28
. Considering hospital profile, the domination of community acquired 
infections was not unexpected, although our hospital also admits patients for 
treatment of HCAI acquired in other hospitals. In all three PPSs, the same four 
diagnoses (UTI, NDS, SSTBJ, GI) were the most frequent diagnoses leading to 
antibiotic use, with variable ranking among them (Figure 1).  
 
The most commonly prescribed antibiotics were ceftriaxone, co-amoxiclav and 
ciprofloxacin which is consistent with most of the findings of similar surveys 
conducted in other European countries 
5,15,19,26,27,28,29
. Croatia is a country where 
penicillins represent the most frequently used antibiotic class in the hospitals and 
the proportion of the narrow spectrum penicillins is substantial 
9
. 
 
In our hospital, 
the narrow spectrum penicillins were mostly used for skin and soft tissue 
infections.  
 
During the PPS audit the most time consuming task was assessing the 
appropriateness of antibiotic therapy and it required a high level of expertise from 
the auditor. According to diagnosis and/or results of relevant cultures, it was 
possible to estimate if the therapy was adequately covering an expected or proven 
pathogen. However, reasons why first line antibiotics were not used were rarely 
stated in the notes. Hence, full compliance with the guidelines that offer numerous 
options for different kind of patients was difficult to assess without an interview 
with the attending physician which is even more time consuming and was not 
feasable in this study. Considering that all antibiotics were prescribed by 
infectious disease doctors it is not surprising that the rates of adequate treatment 
were very high for all categories of diagnosis. However, compliance with 
recommendations for first line antibiotic was low for some clinical indications, 
such as upper respiratory tract infections (ENT) (23%) and infections with no 
defined site (NDS) (34%) in particular, followed by lower respiratory tract and 
urinary tract infections (52% each) (Table 3). Ceftriaxone was largely used for the 
upper respiratory tract infections (50%) although this treatment option was not in 
the local guidelines at all. A shift towards a greater use of ceftriaxone was also 
recorded for UTI. This is a reflection of a general trend towards the increase in 
hospital use of the third generation cephalosporins in most European countries 
9
.  
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We also expected a greater proportion of narrow spectrum penicillins in the 
treatment of lower respiratory tract infections which would be in accordance with 
the local guidelines for patients with pneumonia < 65 years old and admitted to 
the hospital. The weakness of this study is that based on the methodology of data 
collection it was difficult to assess to what extent the deviation from the first line 
treatment was clinically justified. The majority of other similar studies have also 
showed low compliance rate with the local guidelines 
17
, but in the studies carried 
out in Norway, Switzerland or Israel the appropriateness of antibiotic use was 
reported at high rates (96% with positive bacteriological samples and 84% 
without; 71% and 80+/-9%, respectively) 
26,30,31
. 
 
National guidelines on antibiotic use may be of great help for individual hospitals 
when writing or updating local guidelines. In 2007 the Croatian Intersectorial 
Coordination Mechanism (ICM) for antibiotic resistance control 
(Interdisciplinarna sekcija za kontrolu antibiotika, ISKRA) started writing national 
guidelines on prudent antibiotic use. This action was undertaken following the 
MATRA Pre-Accession Programme (MPAP) project „Antimicrobial resistance 
surveillance in human medicine" financed by the Dutch Ministry of Foreign 
Affairs. This project enabled a close collaboration between ISKRA and the Dutch 
Working Party on Antibiotic Policy (Stichting Werkgroep Antibiotica Beleid, 
SWAB) in the field of writing evidence based guidelines. So far, the Croatian 
national guidelines on MRSA treatment and control, urinary tract infections, sore 
throat and surgical prophylaxis have been published 
32,33,34,35
.
 
 New ISKRA 
guidelines covering other clinical topics are underway. Based on the experience of 
PPSs conducted at the University Hospital for Infectious Diseases, ISKRA plans 
to extend a nationwide PPS on antibiotic use in hospitals. This study demonstrates 
that PPS is a useful tool for selecting areas that need improvement and performed 
nationwide could point out the topics that should have a priority in national 
guideline writing. Also PPS can be used as a tool to monitor the effect of 
interventions such as the introduction or revision of local or national guidelines 
18,36
.  
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Despite limitations of the study considering data on compliance, PPSs conducted 
in our hospital clearly revealed targets for quality improvement. It is important to 
find a way of data collection that is relatively simple and feasible in practice, so 
that a PPS can be conducted regularly as a simple and inexpensive method for 
monitoring and evaluation of antibiotic prescribing and use. 
 
We conclude that there was no significant undertreatment of patients receiving 
antibiotics in our hospital but considering very low proportion of patients 
receiving first line antibiotic for upper respiratory tract infections, lower 
respiratory tract infections, infections with no defined site and urinary tract 
infections we presume there is a significant overuse of antibiotics for these 
indications. Therefore we intend to conduct a more detailed survey focusing on 
this problem. We also conclude that local guidelines for our hospital should be 
revised as they are offering too many choices of antibiotic treatment for each 
clinical indication.  
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Figure 1. The proportion of diagnoses leading to antibiotic use 
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SSTBJ skin and soft tissue together with bone and joint infections; UTI urinary tract infections; NDS no defined site 
infections (bacteriaemia with no clear anatomical site, or systemic inflammatory response with no clear anatomical 
site, and completely undefined site with no systemic inflammation); GI gastro intestinal infections (prophylaxis in 
neutropenic patients, GI infections, intra - abdominal sepsis); RESP respiratory infections (pneumonia, bronchitis, 
prophylaxis of respiratory pathogens); ENT ear, nose, throat infections; CNS central nervous system infections; 
CVS cardiovascular infections (cardiovascular infections, endocarditis); GUOB obstetric or gynaecological 
infections (sexually transmitted diseases (STD) in women, prostatitis, epididymo-orchitis and STD in men – GUM. 
 
 
  
Figure 2. The ranking of antibiotics used 
 
 
 
 
 
 
*narrow spectrum penicillins – benzylpenicillin, benzathine benzylpenicillin, procaine benzylpenicillin 
*penicillinase resistant penicillins – cloxacillin, flucloxacillin 
**others = azithromycin, fluconazole, imipenem/cilastatin, meropenem, doxycycline, piperacillin/tazobactam, cefazolin, 
cefixime, moxifloxacin, netilmicin, amphotericin B, moxifloxacin, cefepime, cefuroxime, doripenem, nitrofurantoin, rifampicin, 
amikacin, cefalexin, cefotaxim, ceftazidim, ceftibuten, ertapenem, etambutol, isoniazid B6, clarithromycin, norfloxacin, 
pyrazinamide 
 
 
